NCT03966560View on ClinicalTrials.gov

Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle Glaucoma

PHASE4CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

April 30, 2015

Conditions
Glaucoma, Open-Angle
Interventions
DRUG

Brimonidine Tartrate

Brimonidine tartrate 0.15% 1 eye drop, every day for 6-months

DRUG

Dorzolamide (as Dorzolamide Hydrochloride) 20 Mg/mL and Timolol (as Timolol Maleate) 5 Mg/mL Eye Drops

Dorzolamide and timolol fixed combination 2 eye drops, every day for 6 months

DRUG

Brinzolamide/Timolol 10 MG/1 ML-5 MG/1 ML Ophthalmic Suspension

Brinzolamide and timolol fixed combination 2 eye drops, every day for 6 months

DRUG

Travoprost and Timolol

Travoprost and Timolol fixed combination 1 eye drop, every day for 6 months

DRUG

Bimatoprost and Timolol

Bimatoprost and Timolol fixed combination 1 eye drop, every day for 6 months

DRUG

Latanoprost

Latanoprost 0.005% 1 eye drop, every day for 6 months

All Listed Sponsors
lead

Afyon Kocatepe University Hospital

OTHER

NCT03966560 - Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle Glaucoma | Biotech Hunter | Biotech Hunter